Efficacyof the qiangganzaisheng pill and nifedipine alone andin combina-tion in treatment of the cirrhosis related hepatitis

Abstract

Abstract: AIM: To observe efficacyof the qiang-ganzaisheng pill and nifedipine alone andin combination in the treatment of the cirrhosis related hepatitis (CRH).METHODS: The 64 cases of the patients with CRH were randomly dividedinto three groups:the qiangganzaisheng pill group, the nifedipine group and qiangganzaisheng + nifedipine group.Each treatment lasted for 3 mon.RESULTS: The clinical curative effect of qiangganzaisheng pill and nifedipine in combination was better than that of qiangganzaisheng pill or nifedipine alone.CONCLUSION: The clinical efficacyof qiangganzaisheng pill and nifedipine usedin combination in the treatment of CRH is remarkable.

Key words: qiangganzaisheng pill, nifedipine, cir-rhosis, hepatitis

CLC Number:

R975

ZHANG Ai-Sheng. Efficacyof the qiangganzaisheng pill and nifedipine alone andin combina-tion in treatment of the cirrhosis related hepatitis[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(3): 255-256.

[1]	QI Linling, LIU Shourong. Research progress of tenofovir alafenamide in blocking mother-to-child transmission of hepatitis B virus [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 578-582.
[2]	CAI Zuhuan, DENG Taomei, WEI Naijie, ZHU Dan, QIAN Fei, WANG Guangji, ZHANG Jingwei. Silybin ameliorates lipid metabolism disorders in mice with non-alco-holic steatohepatitis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 241-248.
[3]	TAO Chengjing, LIU Shourong, CHENG Xiaoxian, HU Jiannv, BAI Xiuli, ZHANG Suying, ZHAO Chun, ZUO Zhongbao. Effects of different postpartum withdrawal time of tenofovir on hepatitis B virus markers, virology and biochemical indexes [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1146-1152.
[4]	ZHAI Shuo，LI Na，CHEN Beining，KOU Junping，XING Weifan，ZHANG Pinghu. Prospective of a natural remedy, silymarin from milk thistle, for treating chronic hepatitis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 573-579.
[5]	ZENG Chuanli, HU Airong, HU Yaoren, YUAN Gang, ZHU Dedong, SHI Xiaojun. Clinical effect of entecavir combined with probiotics on treatment of patients with hepatitis B cirrhosis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 796-801.
[6]	ZHOU Yong, YING Li, XU Jiajia, DING Shixiong, HU Airong, GAO Guosheng. Effects of soluble human leukocyte antigen G on the standardized treatment of hepatitis C patients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 809-813.
[7]	YUAN Gang, HU Airong, HU Yaoren, ZENG Chuanli, ZHU Dedong, SHI Xiaojun. Clinical efficacy and long-term prognosis of entecavir and adefovir dipivoxil in the treatment of compensatory hepatitis B cirrhosis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 170-174.
[8]	DU Meisu, YANG Bo, LIU Xueqin, WEI Guohui, ZHANG Xinxia, HAN Zongqi, GUO Minying. Antagonistic effects of nisoldipine on the contractile response of human uterine artery [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 55-58.
[9]	CHEN Yonghua, CAO Qunfen, HONG Qiongyi, WANG Shumin. Effect of tenofovir disoproxil fumarate on serum FGF-23，β2-MG，Cys-C and RBP level in patients with chronic hepatitis B [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 799-804.
[10]	CAI Zhao-bin, WANG Fu-gen, ZHUANG Rang-xiao, FANG Hong-ying, SHAO Yi-dan, XI Jian-jun, PAN Xu-wang, SHI Ting-ting, LIANG Wei-feng. Effects of acetylcysteine taurine magnesium salt on lipid metabolism of NASH in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(11): 1206-1210.
[11]	ZHU Hong-xia, WANG Xue-feng, XU Qian. Clinical comparative study on nifedipine sustained release tablets combined separately with enalapril maleate tablets and metoprolol tartrate tablets in treating high-risk hypertensive patients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1167-1170.
[12]	WANG Xiang-ming, LV Kun, ZHANG Fan, ZHANG Ying-ying, ZHONG Min, LI Jia-jia, MEI Jing-jing. Effect of microRNA let-7a on Con A-induced hepatitis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(7): 738-742.
[13]	PAN Qing-chun, YU Yong-sheng, TANG Zheng-hao, XI Min, ZANG Guo-qing. Serum IL-21 levels in patients with chronic hepatitis C and clinical significance of IL-21 [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(2): 190-194.
[14]	TANG Yu-yan, LI Dan, YU Yong-sheng. The advances of plasmacytoid dendritic cells (pDCs) in chronic hepatitis B [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(9): 1062-1066.
[15]	ZHU Jun-feng, LIN Yan, LI Yong, YU Sheng. Clinical observation on the treatment of nonalcoholic steatohepatitis with liver soothing and lipid reducing decoction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(6): 682-686.

Efficacyof the qiangganzaisheng pill and nifedipine alone andin combina-tion in treatment of the cirrhosis related hepatitis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments